Overview
MOLN market data
Price History
MOLN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.65 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.39 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -866.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.66 – $3.96 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $130.8M · P/B 1.70 · P/S 15.31.
Company News
Molecular Partners Reports Nine Active Trial Sites And Ongoing Treatment In Phase 2 MP0317 Cholangiocarcinoma Study, With Data Update Expected In 2027 And Completion In 2028Benzinga · Jul 16, 2026, 5:47 AM
Molecular Partners Highlights Multispecific Radio-DARPins Formatted As Bispecific Or 2-In-1 DuoDARPin To Address Tumor HeterogeneityBenzinga · Jul 15, 2026, 5:34 AM
Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation SummitGlobenewswire Inc · May 26, 2026, 8:15 PM